ResearcherNagasaki UniversityActive in the last 2 years
Hajime Imamura
Matched on ORCID iD 0000-0002-7205-7757; OpenAlex author ID A5068423067, A5136445420. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- Feasibility of serial cfDNA measurement after perflubutane microbubble (Sonazoid®) administration in patients with pancreatic ductal adenocarcinoma: a first-in… Co-author DOI 10.1186/s13104-026-07869-5↗
- A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Ja… Co-author DOI 10.1186/s12885-024-11957-9↗
- Stress exacerbates pancreatic cancer both directly and indirectly by creating an immunosuppressive environment. Co-author DOI 10.1002/jhbp.1295↗
- Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.15802↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hajime Matsushima · 3 shared papers, 2022–2026 · strength 0.55
- Paper Feasibility of serial cfDNA measurement after perflubutane microbubble (Sonazoid®) administration in patients with panc… DOI 10.1186/s13104-026-07869-5↗
- Paper Stress exacerbates pancreatic cancer both directly and indirectly by creating an immunosuppressive environment. DOI 10.1002/jhbp.1295↗
- Paper Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.15802↗
- Susumu Eguchi · 3 shared papers, 2022–2026 · strength 0.55
- Paper Feasibility of serial cfDNA measurement after perflubutane microbubble (Sonazoid®) administration in patients with panc… DOI 10.1186/s13104-026-07869-5↗
- Paper Stress exacerbates pancreatic cancer both directly and indirectly by creating an immunosuppressive environment. DOI 10.1002/jhbp.1295↗
- Paper Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.15802↗
- Masaaki Hidaka · 2 shared papers, 2022–2023 · strength 0.30
- Takahiro Ikeda · 1 shared paper, 2023 · strength 0.18
- Amane Takahashi · 1 shared paper, 2024 · strength 0.15
- Hiroaki Nagano · 1 shared paper, 2024 · strength 0.15
- Shintaro Yagi · 1 shared paper, 2024 · strength 0.15
- Yusuke Sano · 1 shared paper, 2024 · strength 0.15
- Junki Mizusawa · 1 shared paper, 2024 · strength 0.15
- Keiko Kamei · 1 shared paper, 2024 · strength 0.15
- Yuji Kitahata · 1 shared paper, 2024 · strength 0.15
- Naoto Gotohda · 1 shared paper, 2024 · strength 0.15
- Kohei Nakata · 1 shared paper, 2024 · strength 0.15
- Masafumi Nakamura · 1 shared paper, 2024 · strength 0.15
- Hiroshi Kurahara · 1 shared paper, 2024 · strength 0.15
- Naoto Yamamoto · 1 shared paper, 2024 · strength 0.15
- Daisuke Ban · 1 shared paper, 2024 · strength 0.15
- Seiko Hirono · 1 shared paper, 2024 · strength 0.15
- Etsuro Hatano · 1 shared paper, 2024 · strength 0.15
- Makoto Ueno · 1 shared paper, 2024 · strength 0.15
- Naoki Ikenaga · 1 shared paper, 2024 · strength 0.15
- Michiaki Unno · 1 shared paper, 2024 · strength 0.15
- Takayuki Tanaka · 1 shared paper, 2022 · strength 0.13
- Tamotsu Kuroki · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.